Literature DB >> 6205403

G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene.

F S Collins, C J Stoeckert, G R Serjeant, B G Forget, S M Weissman.   

Abstract

Hereditary persistence of fetal hemoglobin (HPFH) is a benign condition in which the normal shutoff of fetal hemoglobin (Hb F) production fails to occur. In the G gamma beta+ type of HPFH, erythrocytes of adult heterozygotes contain approximately equal to 20% Hb F, which is almost exclusively of the G gamma-globin variety, without increased levels of gamma-globin chains from the nearby A gamma-globin gene. Unlike some forms of HPFH, no major deletions in the globin gene cluster have been found by genomic blotting in the G gamma beta+ variety. We report here a family with this condition, from which cosmid clones of the beta-globin gene cluster from the G gamma beta+ HPFH allele have been obtained. Sequencing around the fetal genes has identified a point mutation 202 base pairs 5' to the G gamma-globin gene that is present in genomic DNA of 3/3 unrelated individuals with G gamma beta+ HPFH but in none of more than 100 non-HPFH individuals. Although the mutation could represent a tightly linked polymorphism, its location in a region suggested by recent data to be important in tissue-specific control of gene expression suggests the possibility that the -202 mutation accounts for the phenotype. The sequence created resembles elements of other eukaryotic promoters known to be important for efficient transcription.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205403      PMCID: PMC391598          DOI: 10.1073/pnas.81.15.4894

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Fetal haemoglobin in homozygous sickle cell disease.

Authors:  G R Serjeant
Journal:  Clin Haematol       Date:  1975-02

2.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

Review 3.  Hereditary persistence of fetal haemoglobin (HPFH) and delta beta thalassaemia.

Authors:  W G Wood; J B Clegg; D J Weatherall
Journal:  Br J Haematol       Date:  1979-12       Impact factor: 6.998

4.  Heterocellular hereditary persistence of fetal haemoglobin (heterocellular HPFH) and its interaction with beta thalassaemia.

Authors:  W G Wood; D J Weatherall; J B Clegg; T J Hamblin; J H Edwards; A M Barlow
Journal:  Br J Haematol       Date:  1977-08       Impact factor: 6.998

5.  Identification of a nondeletion defect in alpha-thalassemia.

Authors:  Y W Kan; A M Dozy; R Trecartin; D Todd
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

6.  Restriction endonuclease mapping of the human gamma globin gene loci.

Authors:  D Tuan; P A Biro; J K deRiel; H Lazarus; B G Forget
Journal:  Nucleic Acids Res       Date:  1979-06-11       Impact factor: 16.971

7.  Heterogeneity in the molecular basis of hereditary persistence of fetal haemoglobin.

Authors:  D Tuan; M J Murnane; J L deRiel; B G Forget
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

8.  Resolution of hemoglobin subunits by electrophoresis in acid urea polyacrylamide gels containing Triton X-100.

Authors:  G Rovera; C Magarian; T W Borun
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

9.  Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia.

Authors:  M E Pembrey; W G Wood; D J Weatherall; R P Perrine
Journal:  Br J Haematol       Date:  1978-11       Impact factor: 6.998

10.  Characterisation of deletions which affect the expression of fetal globin genes in man.

Authors:  E F Fritsch; R M Lawn; T Maniatis
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

View more
  40 in total

1.  Synergistic activation of a human promoter in vivo by transcription factor Sp1.

Authors:  G M Anderson; S O Freytag
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Introduction of Francis S. Collins.

Authors:  David Ginsburg
Journal:  J Clin Invest       Date:  2015-08-17       Impact factor: 14.808

Review 3.  Control of globin gene expression during development and erythroid differentiation.

Authors:  George Stamatoyannopoulos
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

4.  Analysis of 5' flanking regions of the gamma globin genes from major African haplotype backgrounds associated with sickle cell disease.

Authors:  S R Month; R W Wood; P T Trifillis; P J Orchowski; B Sharon; S K Ballas; S Surrey; E Schwartz
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

5.  A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression.

Authors:  S Fucharoen; K Shimizu; Y Fukumaki
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

6.  Translocation of an erythroid-specific hypersensitive site in deletion-type hereditary persistence of fetal hemoglobin.

Authors:  J T Elder; W C Forrester; C Thompson; D Mager; P Henthorn; M Peretz; T Papayannopoulou; M Groudine
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

7.  Functional profile of the human fetal gamma-globin gene upstream promoter region.

Authors:  H J Lin; C Y Han; A W Nienhuis
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

8.  Point mutation associated with hereditary persistence of fetal hemoglobin decreases RNA polymerase III transcription upstream of the affected gamma-globin gene.

Authors:  D P Carlson; J Ross
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

9.  Regulated expression of the human beta globin gene in transgenic mice requires an upstream globin or nonglobin promoter.

Authors:  K P Anderson; J A Lloyd; E Ponce; S C Crable; J C Neumann; J B Lingrel
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

10.  Human gamma- to beta-globin gene switching using a mini construct in transgenic mice.

Authors:  J A Lloyd; J M Krakowsky; S C Crable; J B Lingrel
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.